Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids

Journal of Clinical Investigation

Volumn 110, Issue 11, 2002, Pages 1729-1738

  Limbourg, Florian P ^a   Huang, Zhihong ^b   Plumier, Jean Christophe ^b   Simoncini, Tommaso ^c   Fujioka, Masayuki ^b   Tuckermann, Jan ^d   Schütz, Günther ^d   Moskowitz, Michael A ^b   Liao, James K ^a,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF PISA   (Italy)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CORTICOSTEROID; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; LIGAND; MIFEPRISTONE; MUTANT PROTEIN; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; DIMERIZATION; DNA BINDING; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STROKE; VASODILATATION;

EID: 0036897343     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215481     Document Type: Article

References (57)

1. Hollenberg, S.M., et al. 1985. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 318:635-641.
2. Beato, M., Herrlich, P., and Schutz, G. 1995. Steroid hormone receptors: Many actors in search of a plot Cell. 83:851-857.
3. Cole, T.J., et al. 1995. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev, 9:1608-1621.
4. Reichardt, H.M., Umland, T., Bauer, A., Kretz, O., and Schutz, G. 2000. Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Mol. Cell. Biol. 20:9009-9017.
5. Reichardt, H.M., et al. 1998. DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 93:531-541.
6. Orchinik, M., Murray, T.F., and Moore, F.L. 1991. A corticosteroid receptor in neuronal membranes. Science. 252:1848-1851.
7. Steiner, A., Vogt, E., Locher, R., and Vetter, W. 1988. Stimulation of the phosphoinositide signalling system as a possible mechanism for glucocorticoid action in blood pressure control. J. Hypertens. 6(Suppl.):S366-S368.
8. Inagaki, N., et al. 1992. Studies on the anti-allergic mechanism ofglucocorticoids in mice. J. Pharmacobiodyn. 15:581-587.
9. Kousteni, S., et al. 2001. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity. Cell. 104:719-730.
10. Chen, Z., et al. 1999. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103:401-406.
11. Simoncini, T., et al. 2000. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 407:538-541.
12. Haynes, M.P., et al. 2000. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the P13-kinase-Akt pathway in human endothelial cells. Circ. Res. 87:677-682.
13. Iadecola, C. 1997. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:132-139.
14. Huang, Z., et al. 1996. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab. 16:981-987.
15. Huang, Z., et al. 1994. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1883-1885.
16. Morikawa, E., et al. 1994. L-arginine infusion promotes nitric oxidedependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke. 25:429-435.
17. Endres, M., et al. 1998. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase, Proc. Natl. Acad Sci. USA. 95:8880-8885.
18. Anderson, D.C., and Cranford, R.E. 1979. Corticosteroids in ischemic stroke. Stroke. 10:68-71.
19. Libby, P., Maroko, P. R., Bloor, C.M., Sobel, B.E., and Braunwald, E. 1973. Reduction of experimental myocardial infarct size by corticosteroid administration. J. Clin. Invest. 52:599-607.
20. Bertorelli, R., Adami, M., Di Santo, E., and Ghezzi, P. 1998. MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain. Neurosci. Lett. 246:41-44.
21. Slivka, A.P., and Murphy, E.J. 2001. High-dose methylprednisolone treatment in experimental focal cerebral ischemia. Exp. Neurol. 167:166-172.
22. de Courten-Mvers, G.M., Kleinholz, M., Wagner, K.R., Xi, G., and Myers, R.E. 1994. Efficacious experimental stroke treatment with high-dose methylprednisolone. Stroke. 25:487-492.
23. Haffezi-Moghadam, A., et al. 2002. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat. Med. 8:473-479.
24. Wallerath, T., et al. 1999. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc. Natl. Acad. Sci. USA. 96:13357-13362.
25. Walsh, J.P., Caldwell, K.K., and Majerus, P.W. 1991. Formation of phosphatidylinositol 3-phosphate by isomerization from phosphatidylinositol 4-phosphate. Proc. Natl. Acad. Sci. USA. 88:9184-9187.
26. Papapetropoulos, A., Garcia-Cardena, G., Madri, J.A., and Sessa, W.C. 1997. Nitric oxide production contributes to the angiogenic arigiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100:3131-3139.
27. Laufs, U., et al. 2000. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J. Clin. Invest. 106:15-24.
28. Mulvany, M.J., and Halpern, W. 1977. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41: 19-26.
29. Swanson, et al. 1990. A semiautomated method for measuring brain inffarct volume. J. Cereb. Blood Flow Metab. 10:290-293.
30. Yamada, M., et al. 2000. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J. Cereb Blood Flow Metab. 20:709-717.
31. Huang, P.L., et al. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase, Nature. 377: 239-242.
32. Dalkara, T., Morikawa, E., Panahian, N., and Moskowitz, M.A. 1994. Blood flow-dependent functional recovery in a rat model of focal cerebral ischemia. Am. J. Physiol. 267:H678-H683.
33. Dimmeler, S., et al. 1999. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 399:601-605.
34. Fulton, D., et al. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 399:597-601.
35. Rameh, L.E., and Cantley, L.C. 1999. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem, 274:8347-8350.
36. Burgering, B.M., and Coffer, P.J. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:599-602.
37. Moreno, M., et al. 2002. Are the effects of T3 on resting metabolic rate in euthyroid rats entirely caused by T3 itself? Endocrinology. 143:504-510.
38. Heck, S., et al. 1994. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13:4087-4095.
39. Bauer, R.B., and Tellez, H. 1973. Dexamethasone as treatment in cerebrovascular disease. 2. A controlled study in acute cerebral infarction. Stroke. 4:547-555.
40. Norris, J.W., and Hachinski, V.C. 1986. High dose steroid treatment in cerebral infarction. Br Med. J. (Clin. Res. Ed.) 292:21-23.
41. Norris, J.W. 1976. Steroid therapy in acute cerebral infarction. Arch. Neurol. 33:69-71.
42. Mulley, G., Wilcox, R.G., and Mitchell, J.R. 1978. Dexamethasone in acute stroke. Br. Med. J. 2:994-996.
43. Patten, B.M., Mendell, J., Bruun, B., Curtin, W., and Carter, S. 1972. Double-blind study of the effects ofdexamethasone on acute stroke. Neurology. 22:377-383.
44. Sapotsky, R.M., and Pulsinelli, W.A. 1985. Glucocorticoids potentiate ischemic injury to neurons: Therapeutic implications. Science. 229:1397-1400.
45. Bracken, M.B., et al. 1984. Efficacy of methylprednisolone in acute spinal cord injury. JAMA. 251:45-52.
46. Bracken, M.B., et al. 1990. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N. Engl. J. Med. 322:1405-1411.
47. Leker, R.R., et al. 2001. Expression of endothelial nitric oxide synthase in the ischemic penumbra: Relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor. Brain Res. 909:1-7.
48. Danton, G.H., Prado, R., Truetrner, J., Watson, B.D., and Dietrich, W.D. 2002. Endothetial nitric oxide synthase pathophysiology after nonocclusive common carotid artery thrombosis rats. J. Cereb. Blood Flow Metab. 22:612-619.
49. Del Zoppo, GJ., and Hallenbeck, J.M. 2000. Advances in the vascular parhophysiology of ischemic stroke. Thromb. Res. 98:73-81.
50. Cronstein, B.N., Kimmel, S.C., Levin, R.I., Martiniuk, F., and Weissmann, G. 1992. A mechanism flor the antiinflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule I and intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 89:9991-9995.
51. Zhang, F., and Iadecola, C. 1994 Reduction of focal cerebral ischemic damage by delayed treatment with nitric oxide donors. J. Cereb. Blood Flow Metab. 14:574-580.
52. Datta, S.R., et al. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:231-241.
53. Fujio, Y., Nguyen, T., Wencker, D., Kitsis, R.N., and Walsh, K. 2000. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 101:660-667.
54. Brunet, A., et al. 2001. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription Factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21:952-965.
55. Moran, T.J., Gray, S., Mikosz, C.A., and Conzen, S.D. 2000. The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res. 60:867-872.
56. Park, J., et al. 1999. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J. 18:3024-3033.
57. Vayssiere, B.M., et al. 1997. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol. Endocrinol. 11: 1245-1255.